Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

March 17, 2026

APOE4 gene variant linked to greater nerve damage in MS: Study

  • MS Cognition
    /
  • Nerve Damage
    /
  • Multiple Sclerosis (MS) Symptoms
    /
Carriers also showed signs of cognitive decline, more brain tissue damage Written by Patricia Inacio, PhD | March 17, 2026 A genetic variant…
MS Cognition

March 17, 2026

High Epstein-Barr antibody levels over time may aid MS diagnosis

  • Epstein Barr (EBV)
    /
  • MS Research Study and Reports
    /
Study points to potential way to distinguish MS from other conditions Written by Marisa Wexler, MS | March 16, 2026 Most people with multiple…
Epstein Barr (EBV)

March 17, 2026

Stopping Ocrevus in stable MS doesn’t seem to raise 2-year risk, study finds

  • MS Infusion Treatments
    /
  • Ocrevus
    /
But patients should restart treatment after 2.5 years or disease activity Written by Marisa Wexler, MS | March 17, 2026 For people with multiple…
MS Infusion Treatments

March 17, 2026

Online Survey: Stress and MS – from the National MS Society

  • MS Research Study and Reports
    /
  • National MS Society Related
    /
March 2026   Kenneth, diagnosed in 2014   Researchers are committed to finding solutions for everyone affected by MS. Without…
MS Research Study and Reports

March 17, 2026

High-Altitude Gene Helps Heal Myelin Damage

  • Misc. MS Related
    /
  • Myelin Repair
    /
Neuroscience·March 13, 2026 Summary: Evolutionary adaptations that allow animals like yaks and Tibetan antelopes to thrive at 14,700 feet may provide…
Misc. MS Related

March 11, 2026

Talking Biosimilars – Unlocking Patient access through coordinated action

  • Biosimilars
    /
  • MS Drug Therapies
    /
FIRST, Click this link https://www.sandoz.com/business/biosimilars/talking-biosimilars/ to access the report. After the website page opens, CLICK the image that reads Download,,…
Biosimilars

March 5, 2026

Beyond One Drug: What the Tolebrutinib Decision Teaches Us About Progressive MS Trials.

  • Healthcare Perspectives
    /
  • MS Drug Therapies
    /
Reflections on risk, biology, and the trials progressive MS now demands Feb 03, 2026 – by: Leorah Freeman, MD, PhD…
Healthcare Perspectives

March 2, 2026

MS Trial Alert: Investigators Recruiting Nationwide for Study Comparing AHSCT to Other Therapies in Active Relapsing MS

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Stem Cell Related
    /
Researchers are committed to finding solutions for everyone affected by MS. Without participants—like you—in research studies, MS research would come…
MS Research Study and Reports

March 2, 2026

Genentech’s Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)

  • BTK Inhibitors
    /
  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
– FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide in relapsing…
BTK Inhibitors

March 1, 2026

Eating well with MS can be an effective in managing symptoms

  • Nutrition
    /
While there isn’t an established multiple sclerosis (MS) diet plan, eating well with MS can be an effective way to manage symptoms…
Nutrition

Categories

Latest Blog Posts